Debt-to-equity of Propanc Biopharma, Inc. from 31 Mar 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Propanc Biopharma, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2020 to 31 Dec 2025.
  • Propanc Biopharma, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 31%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 31% +132% 31 Dec 2025
Q3 2025 43% +145% 30 Sep 2025
Q2 2025 78% +182% 30 Jun 2025
Q1 2025 276% +380% 31 Mar 2025
Q4 2024 -102% +3.4% +3.2% 31 Dec 2024
Q3 2024 -103% +1.4% +1.3% 30 Sep 2024
Q2 2024 -104% -0.33% -0.32% 30 Jun 2024
Q1 2024 -104% -0.22% -0.21% 31 Mar 2024
Q4 2023 -105% -1.1% -1% 31 Dec 2023
Q3 2023 -104% -0.21% -0.2% 30 Sep 2023
Q2 2023 -103% +0.32% +0.31% 30 Jun 2023
Q1 2023 -104% -0.52% -0.5% 31 Mar 2023
Q4 2022 -104% -2% -2% 31 Dec 2022
Q3 2022 -104% -2.7% -2.7% 30 Sep 2022
Q2 2022 -104% -2.5% -2.5% 30 Jun 2022
Q1 2022 -103% -1.3% -1.3% 31 Mar 2022
Q4 2021 -102% -0.06% -0.06% 31 Dec 2021
Q3 2021 -101% +0.56% +0.54% 30 Sep 2021
Q2 2021 -101% +1% +1% 30 Jun 2021
Q1 2021 -102% +0.4% +0.39% 31 Mar 2021
Q4 2020 -102% 31 Dec 2020
Q3 2020 -102% 30 Sep 2020
Q2 2020 -102% 30 Jun 2020
Q1 2020 -102% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.